Dr. Amy Boyle is a scientist with the Brain Health Imaging Centre (BHIC) and an assistant professor in the Department of Psychiatry, Division of Neurosciences and Clinical Translation at the University of Toronto (UofT).
Dr. Boyle worked in the Pharmacy Department at the UofT for five years in positron emission tomography (PET) radiopharmaceutical development and preclinical oncology imaging prior to obtaining her PhD in Radiopharmaceutical Sciences from UofT. With over 10 years of PET imaging experience and radiopharmaceutical development, Dr. Boyle joined the BHIC at CAMH for her postdoctoral training, supported by the 2020 Discovery Fund Talent Competition, and then as an independent scientist, applying her knowledge of PET imaging oncology to the study of neuroinflammation and neurodegenerative diseases, and neuro-oncology.
Dr. Boyle’s accomplishments include receiving the Alavi-Mandell Award for an outstanding publication in the Journal of Nuclear Medicine and being invited to the Future Leaders Academy by Society of Nuclear Medicine and Molecular Imaging (SNMMI). She is a board member of the Center of Molecular Imaging and Innovation Translation (CMIIT) within the SNMMI as well as a member of their Equity, Diversity, and Inclusion Taskforce.
Areas of Research
Dr. Boyle’s area of research involves using PET imaging to study neuroinflammation, neurodegeneration, and neuro-oncology in the living body. For example, she’s investigating different biomarkers of neuroinflammation in multiple sclerosis (MS) to find a strategy for early diagnosis. She’s also looking for sex differences in these biomarkers to identify personalized treatment strategies for males and females, for whom the presentation of MS differs dramatically.
Dr. Boyle is also investigating neuro-oncology through studying neuroinflammation and neuro-tumour crosstalk.
Publications
View Dr. Boyle’s publications on PubMed.